Nazwa produktu: |
Zmienna mieszanina K-strofantyny |
Synonimy |
k-Strophanthoside; NSC 7530; STROPHANTHOSIDE-K; Strofantydyna cymaroza beta-glukoza alfa-glukoza; Strofantydyna cymaroza beta-glukoza alfa-glukoza [niemiecki]; k-Strofantozyd; k-Strofantozyd [polski]; k-Strophanthidin-gamma; k-Strophantosid; k-Strophantosid [niemiecki]; k-strofantozyd; (3beta,5beta)-3-((O-beta-D-glukopiranozylo-(1,6)-O-beta-D-glukopiranozylo-(1,4)-2,6-dideoksy-3-O-metylo-beta-D-rybo-heksopiranozylo)-5,14-dihydroksy-19-oksocard-20(22)-enolid; 5-beta-Card-20(22)-enolid, 3-beta-((O-beta-D-glukopiranozylo-(1-6)-O-beta-D-glukopiranozylo-(1-4)-2,6-dideoksy-3-O-metylo-beta-D-rybo-heksopiranozylo)oksy)-5,14-dihydroksy-19-okso-; Card-20(22)-enolid, 3-((O-beta-D-glukopiranozylo-(1-6)-O-beta-D-glukopiranozylo-(1-4)-2,6-dideoksy-3-O-metylo-beta-D-rybo-heksopirozylo)oksy)-5,14-dihydroksy-19-okso-, (3beta,5beta)-(9CI); 3-{[heksopiranozylo-(1->6)heksopiranozylo-(1->4)-2,6-dideoksy-3-O-metyloheksopiranozylo]oksy}-5,14-dihydroksy-19-oksokarda-20(22)-enolid; (3beta,5beta,17xi)-3-{[beta-D-glukopiranozylo-(1->6)-beta-D-glukopiranozylo-(1->4)-2,6-dideoksy-3-O-metylo-beta-D-rybo-heksopiranozylo]oksy}-5,14-dihydroksy-19-oksokarda-20(22)-enolid |
Angielska nazwa |
K-strophanthin variable mixture;k-Strophanthoside; NSC 7530; STROPHANTHOSIDE-K; Strophanthidin + cymarose + beta-glucose + alpha-glucose; Strophanthidin + cymarose + beta-glucose + alpha-glucose [German]; k-Strofantozyd; k-Strofantozyd [Polish]; k-Strophanthidin-gamma; k-Strophantosid; k-Strophantosid [German]; k-Strophantoside; (3beta,5beta)-3-((O-beta-D-glucopyranosyl-(1.6)-O-beta-D-glucopyranosyl-(1.4)-2,6-dideoxy-3-O-methyl-beta-D-ribo-hexopyranosyl)oxy)-5,14-dihydroxy-19-oxocard-20(22)-enolide; 5-beta-Card-20(22)-enolide, 3-beta-((O-beta-D-glucopyranosyl-(1-6)-O-beta-D-glucopyranosyl-(1-4)-2,6-dideoxy-3-O-methyl-beta-D-ribo-hexopyranosyl)oxy)-5,14-dihydroxy-19-oxo-; Card-20(22)-enolide, 3-((O-beta-D-glucopyranosyl-(1-6)-O-beta-D-glucopyranosyl-(1-4)-2,6-dideoxy-3-O-methyl-beta-D-ribo-hexopyranosyl)oxy)-5,14-dihydroxy-19-oxo-, (3beta,5beta)- (9CI); 3-{[hexopyranosyl-(1->6)hexopyranosyl-(1->4)-2,6-dideoxy-3-O-methylhexopyranosyl]oxy}-5,14-dihydroxy-19-oxocard-20(22)-enolide; (3beta,5beta,17xi)-3-{[beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranosyl-(1->4)-2,6-dideoxy-3-O-methyl-beta-D-ribo-hexopyranosyl]oxy}-5,14-dihydroxy-19-oxocard-20(22)-enolide |
MF |
C42H64O19 |
Masie cząsteczkowej |
872.9462 |
InChI |
InChI=1/C42H64O19/c1-19-36(61-38-35(51)33(49)31(47)27(60-38)17-56-37-34(50)32(48)30(46)26(15-43)59-37)25(54-3)13-29(57-19)58-21-4-9-40(18-44)23-5-8-39(2)22(20-12-28(45)55-16-20)7-11-42(39,53)24(23)6-10-41(40,52)14-21/h12,18-19,21-27,29-38,43,46-53H,4-11,13-17H2,1-3H3/t19-,21+,22?,23+,24-,25+,26-,27-,29+,30-,31-,32+,33+,34-,35-,36-,37-,38+,39-,40+,41+,42+/m1/s1 |
Nr CAS |
33279-57-1 |
EINECS |
251-439-1 |
Struktury molekularnej |
|
Gęstość |
1.49g/cm3 |
Temperatura wrzenia |
1027.2°C at 760 mmHg |
Współczynnik załamania |
1.631 |
Temperatura zapłonu |
304°C |
Ciśnienie pary |
0mmHg at 25°C |
Symbole zagrożenia |
|
Kody ryzyka |
|
Bezpieczeństwo opis |
|
|